HeraMED Limited (ASX:HMD)
0.0350
0.00 (0.00%)
Nov 16, 2026, 12:32 PM AEDT
HeraMED Market Cap
HeraMED has a market cap or net worth of 40.55 million as of November 16, 2026. It is the 34,346th most valuable company in the world and the 833rd biggest in Australia. Its market cap has increased by 8.10% in one year.
Market Cap
40.55M
Enterprise Value
37.62M
Revenue
330.44K
Global Rank
Country Rank
#833 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since December 12, 2018, HeraMED's market cap has increased from 15.76M to 40.55M, an increase of 157.39%. That is a compound annual growth rate of 12.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 16, 2026 | 40.55M | 5.26% |
| Dec 31, 2025 | 38.53M | 120.00% |
| Dec 31, 2024 | 17.51M | 127.12% |
| Dec 29, 2023 | 7.71M | -74.58% |
| Dec 30, 2022 | 30.33M | -32.86% |
| Dec 31, 2021 | 45.18M | 173.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lumos Diagnostics Holdings | 68.99M |
| SomnoMed | 68.13M |
| Cyclopharm | 59.98M |
| Epiminder | 59.58M |
| Saluda Medical | 49.14M |
| Compumedics | 46.94M |
| Nova Eye Medical | 45.59M |
| Cleo Diagnostics | 37.02M |